Found 481 clinical trials
Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Fundus Images
AEYE-DS is a software device developed to increase compliance with diabetic retinopathy screening by automatically detecting more-than-mild diabetic retinopathy from digital fundus images
- 0 views
- 11 Mar, 2021
- 1 location
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Ophthalmology
-
Currently Recruiting
Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes
We are seeking participants for a new clinical research study to evaluate the long term treatment effects of an investigational medication on diabetic retinopathy progression in adults with
- 72 views
- 14 Jan, 2021
- 1 location
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Ophthalmology
-
Currently Recruiting
Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Fundus Images
Pivotal Prospective Clinical Trial to Demonstrate the Efficacy and Safety of AEYE-DS Software Device for Automated Diabetic Retinopathy Detection From Digital Fundoscopic Images.
- 0 views
- 11 Mar, 2021
- 1 location
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Currently Recruiting
Are You Currently Taking Basal (Long-Acting) Insulin to Treat Your Type 2 Diabetes?
during the study (10 times during the study where you check your blood sugars at 7 specific time points.) Participants will also receive a dilated Fundoscopic exam to test for retinopathy and macular edema
- 0 views
- 27 Jan, 2021
- 1 location
-
Multi-country trial
-
Phase 3 trial
-
Accepting pediatric ages
-
Accepting Seniors
-
100s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Study to Assess the Efficacy Safety and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity
The primary objective of the study is to assess the efficacy of aflibercept compared to laser in patients diagnosed with retinopathy of prematurity (ROP). The secondary objectives of the study
- 55 views
- 15 Feb, 2021
- 81 locations
-
Multi-country trial
-
Phase 3 trial
-
Accepting pediatric ages
-
100s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090
This is a follow-up study to evaluate the long term outcome of babies treated in the FIREFLEYE study.
- 10 views
- 16 Apr, 2021
- 146 locations
-
Multi-country trial
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy
The purpose of this study is to evaluate the efficacy and safety of brolucizumab compared to panretinal photocoagulation laser (PRP) in patients with proliferative diabetic retinopathy (PDR
- 0 views
- 27 Jan, 2021
- 16 locations
-
Accepting pediatric ages
-
1000s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants
prolonged hypoxemic episodes are associated with retinopathy of prematurity (ROP), impaired long-term development and death. Closed-loop automated control of the inspiratory fraction of oxygen (FiO2-C
- 0 views
- 22 Jan, 2021
- 2 locations
-
Multi-country trial
-
Phase 4 trial
-
Accepting pediatric ages
-
100s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Early CPAP in Respiratory Distress Syndrome
The purpose of this study is to establish if a strategy of EBCPAP application in a subgroup of VLBWI, 800 to 1500g birthweight, decreases the need for mechanical ventilation in this group, without affecting mortality.
- 38 views
- 07 Nov, 2020
- 12 locations
-
Multi-country trial
-
Phase 3 trial
-
Accepting pediatric ages
-
Accepting Seniors
-
100s of participants
-
An interventional trial
-
For all genders
-
Ophthalmology
-
Currently Recruiting
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
Non-infectious intermediate, posterior, and panuveitides are chronic, potentially-blinding diseases. Vision-threatening cases require long-term therapy with oral corticosteroids and immunosuppression. Based upon preliminary data, adalimumab, a fully-human, anti-TNFmonoclonal antibody, now US FDA-approved for uveitis treatment, may be a superior corticosteroid-sparing agent than conventional immunosuppressive drugs. The ADVISE Trial is multicenter randomized, …
- 103 views
- 24 Jan, 2021
- 27 locations